Immune Markers and Ornithine Decarboxylase Activity among Electric Utility Workers

Journal of Occupational and Environmental Medicine

Volumn 46, Issue 2, 2004, Pages 104-112

  Ichinose, Travers Y ^a   Burch, James B ^a   Noonan, Curtis W ^a,b   Yost, Michael G ^c   Keefe, Thomas J ^a   Bachand, Annette ^a   Mandeville, Rosemonde ^d   Reif, John S ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Biophage Pharma Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; ORNITHINE DECARBOXYLASE;

ADULT; ARTICLE; B LYMPHOCYTE; BASOPHIL; CELL COUNT; ELECTRICITY; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; IMMUNE SYSTEM; INDUSTRIAL WORKER; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; OCCUPATIONAL EXPOSURE; PHENOTYPE; T LYMPHOCYTE;

ADULT; BIOLOGICAL MARKERS; COLORADO; ELECTROMAGNETIC FIELDS; HUMANS; KILLER CELLS, NATURAL; LEAST-SQUARES ANALYSIS; LEUKOCYTE COUNT; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MELATONIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; ORNITHINE DECARBOXYLASE;

EID: 0842331306     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000111963.64211.3b     Document Type: Article

References (66)

1. Bassett CA. Beneficial effects of electromagnetic fields. J Cell Biochem. 1993; 51:387-393.
2. Pilla AA, Markov MS. Bioeffects of weak electromagnetic fields. Rev Environ Health. 1994;10:155-169.
3. Nindl G, Balcavage WX, Vesper DN, et al. Experiments showing that electromagnetic fields can be used to treat inflammatory diseases. Biomed Sci Instrum. 2000;36:7-13.
4. Johnson MT, Vanscoy-Cornett A, Swez JA, Chamberlain JK, Seaward MB, Nindl G. Electromagnetic fields used clinically to improve bone healing also impact lymphocyte proliferation in vitro. Biomed Sci Instrum. 2001;37:215-220.
5. Conti P, Gigante GE, Cifone MG, et al. Reduced mitogenic stimulation of human lymphocytes by extremely low frequency electromagnetic fields. FEBS Lett. 1983; 162:156.
6. Walleczek J. Electromagnetic field effects on cells of the immune system: role of calcium signaling. FASEB J. 1992;6: 3177-185.
7. Bonhomme-Faivre L, Bizie E, Marion S, et al. Effects of sub-chronic magnetic field exposure on hematologic parameters in mice. Electro Magnetobiol. 1995; 14:193-197.
8. Mevissen M, Haussler M, Szamel M, Emmendorffer A, Thun-Battersby S, Loescher W. Complex effects of long-term 50-Hz magnetic field exposure in vivo on immune functions in female Sprague-Dawley depend on duration of exposure. Bioelectromagnetics. 1998;19: 259-270.
9. National Institute of Environmental Health Sciences. In: Portier CJ, Wolfe MS, eds. Assessment of Health Effects from Exposure to Power-Line Frequency Electric and Magnetic Fields. [Pub No. 98-3981.] Research Triangle Park, NC: U.S. Dept. Health and Human Services; 1998.
10. Trembley L, Houde M, Mercier G, Gagnon J, Mandeville R. Differential modulation of natural and adaptive immunity in Fischer rats exposed for 6 weeks to 60 Hz linear sinusoidal continuous wave magnetic fields. Bioelectromagnetics. 1996;17:373-383.
11. House RV, McCormick DL. Modulation of natural killer cell function after exposure to 60 Hz magnetic fields: confirmation of the effect in mature B6C3F mice. Radiat Res. 2000;153:722-724.
12. Selmaoui B, Bogdan A, Auzeby A, Lambrozo J, Touitou Y. Acute exposure to 50 Hz magnetic field does not affect hematologic function in healthy young men: a circadian study. Bioelectromagnetics. 1996;17:364-372.
13. Graham C, Sastre A, Cook MR, Gerkovich MM. All-night exposure to EMF does not alter urinary melatonin, 6-OHMS or immune measures in older men and women. J Pineal Res. 2001;31:109-113.
14. Khalil AM, Qassem W, Amoura F. Cytogenetic changes in human lymphocytes from workers occupationally exposed to high-voltage electromagnetic fields. Electro-Magnetobiol. 1993;12:17-26.
15. Bonhomme-Faivre L, Marion S, Bezie Y, Auclair H, Fredj G, Hommeau C. Study of neurovegetative and hematologic effects of environmental low-frequency (50 Hz) electromagnetic fields produced by transformers. Arch Environ Health. 1998; 53:87-92.
16. Dasdag S, Sert C, Akdag Z, Batun S. Effects of extremely low frequency electromagnetic fields on hematologic and immunologic parameters in welders. Arch Med Res. 2002;33:29-32.
17. Del Signore A, Boscolo P, Di Martino G, Giuliano G. Combined effects of traffic and electromagnetic fields on the immune system of fertile atopic women. Industr Health. 2000;38:294-300.
18. Boscolo P, Bergamaschi A. Di Sciascio MB, et al. Effects of low frequency electromagnetic fields on expression of lymphocyte subsets and production of cytokines of men and women employed in a museum. Sci Total Environ 2001; 270:13-20.
19. Boscolo P, Di Sciascio MB, D'Ostilio S, et al. Effects of electromagnetic fields produced by radiotelevision broadcasting stations on the immune system of women. Sci Total Environ. 2001;273:1-10.
20. Tuschl H, Neubauer G, Schmid G, Weber E, Winker N. Occupational exposure to static, ELF, VF and VLF magnetic field and immune parameters. Int J Occ Med Environ Health 2000;13:39-50.
21. Mullins JM, Penafiel A Juutilainen J, Litovitz TA. Dose-response of electromagnetic field enhanced ornithine decarboxylase activity. Bioelectrochem Bioenerg. 1999;48:193-199.
22. Johnson DB, Pero RW, Morgenstern R, Joseph PE, Miller DG. Ornithine decarboxylase in resting human mononuclear leucocytes: evidence for an endogenous inhibitor. Int J Biochem. 1989;21:1169-1175.
23. Janne J, Alhonen. L, Leinonen P. Polyamines from molecular biology to clinical applications. Ann Med 1991;23:241-259.
24. International Agency for Research on Cancer (IARC). Static and Extremely Low-Frequency Electric and Magnetic Fields. Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 80. Lyon, France: IARC; 2001.
25. Wilson BW, Wright CW, Morris JE, et al. Evidence for an effect of ELF electromagnetic fields on human pineal gland function. J Pineal Res. 1990;94:259-269.
26. Pfluger DH, Minder CE. Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers. J Pineal Res. 1996;21:91-100.
27. Wood AW, Armstrong SM, Sait ML, Devine L, Martin MJ. Changes in human plasma melatonin profiles in response to 50 Hz magnetic field exposure. J Pineal Res. 1998;25:116-127.
28. Burch JB, Reif JS, Yost MG, Keefe TJ, Pitrat CA. Nocturnal excretion of a urinary melatonin metabolite in electric utility workers. Scand J Work Environ Health. 1998;24:183-189.
29. Burch JB, Reif JS, Yost MG, Keefe TJ, Pitrat CA. Reduced excretion of a melatonin metabolite in workers exposed to 60 Hz magnetic fields. Am J Epidemiol. 1999;150:27-36.
30. Burch JB, Reif JS, Noonan CW, Yost MG. Melatonin metabolite levels in workers exposed to 60 Hz magnetic fields: work in substations and with 3-phase conductors. J Occup Environ Med. 2000;42:136-142.
31. Burch JB, Reif JS, Noonan CW, et al. Melatonin metabolite excretion among cellular telephone users. Int J Radiat Biol. 2002;78:1029-1036.
32. Juutilainen J, Stevens RG, Anderson LE, et al. Nocturnal 6-hydroxymelatonin sulfate excretion in female workers exposed to magnetic fields. J Pineal Res. 2000;28: 97-104.
33. Davis S, Kaune W, Mirick DK, Chen C, Stevens RG. Residential magnetic fields. light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am J Epidemiol. 2001;154:591-600.
34. Karasek M, Woldanska-Okonska M, Czernicki J, Zylinska K, Swietoslawski J. Influence of low-frequency magnetic field of different characteristics on serum melatonin concentrations in humans. Adv Exp Biol Med. 2000;460:459-462.
35. Graham C, Cook MR, Riffle DW, Gerkovich MM, Cohen HD. Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields. Bioelectromagnetics. 1996;17: 263-273.
36. Graham C, Cook MR, Riffle DW. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics. 1996;18:166-171.
37. Selmaoui B, Lambrozo J, Touitou Y. Magnetic fields and pineal function in humans: evaluation of nocturnal exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci. 1996;58:1539-1549.
38. Graham C, Cook MR, Sastre A, Riffle DW, Gerkovich MM. Multi-night exposure to 60 Hz magnetic fields: effects on melatonin and its enzymatic metabolite. J Pineal Res. 2000;28:1-8.
39. Touitou Y, Lambrozo J, Camus F, Charbuy H. Magnetic fields and the melatonin hypothesis: a study of workers chronically exposed to 50-Hz magnetic fields. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1529-R1535.
40. Liburdy RP, Sloma TR, Sokolic R, Yaswen P. ELF magnetic fields, breast cancer and melatonin: 60-Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation. J Pineal Res. 1993;142:89-97.
41. Blackman CF, Benane SG, House DE. The influence of 1.2 μT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth. Bioelectromagnetics. 2001;22: 122-128.
42. Ishido M, Nitta H, Kabuto M. Magnetic fields (MF) of 50 Hz at 1.2 μT as well as 100 μT cause uncoupling of inhibitory pathways of adenyl cyclase mediated by melatonin la receptor in MF-sensitive MCF-7 cells. Carcinogenesis. 2001;22: 1043-1048.
43. Brezinski A. Melatonin in humans. N Engl J Med. 1997;336:186-195.
44. Angeli A, Gatti G, Sartori ML, Del Ponte D, Cerignola R. Effect of exogenous melatonin on human natural killer (NK) cell activity. An approach to the immunomodulatory role of the pineal gland. In: Gupta D, Attanasio A, Reiter RJ, eds. The Pineal Gland and Cancer. Tubingen, Germany: Muller and Bass; 1986.
45. Fraschini F, Demartini G, Esposti D, Scaglione F. Melatonin involvement in immunity and cancer. Biological Signals Receptor. 1998;7:61-72.
46. Currier NL, Sun LZ-Y, Miller SC. Exogenous melatonin: quantitative enhancement in vivo of cells mediating nonspecific immunity. J Neuroimmunol. 2000;104:101-108.
47. Cardinali DP, Cutrere R, Castrillon P, Esquifino AI. Diurnal rhythms in ornithine decarboxylase activity and norepinephrine and acetylcholine synthesis of rat submaxillary lymph nodes: effect of pinealectomy, superior cervical ganglionectomy, or melatonin replacement. Neuroimmunomodulation. 1996;3:102-111.
48. Cardinali DP, Cutrere R, Castrillon P, Esquifino AI. Effect of pinealectomy, superior cervical ganglionectomy, or melatonin treatment on 24-hour rhythms in ornithine decarboxylase and tyrosine hydroxylase activities of rat spleen. J Pineal Res. 1997;22:210-220.
49. Noonan CW, Reif JS, Burch JB, Ichinose TA, Yost MG, Magnusson K. Relationship between amyloid beta protein and melatonin metabolite in a study of electric utility workers. J Occup Environ Med. 2002;44:769-775.
50. Yost MG. Alternative magnetic field exposure metrics: occupational measurements in trolley workers. Radia Protection Dosimetry. 1999;83:99-106.
51. Owens MA, Loken MR. Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping. New York: Wiley-Liss; 1995.
52. NIH, NIAID Division of AIDS. Guidelines for Flow Cytometric Immunophenotyping. NIH Version 2.0, Bethesda, MD; NIH; January 1993.
53. Kaicer El-K, Mandeville R. Increase in ODC activity in organs of animals exposed to 60 Hz linear, sinusoidal continuous-wave magnetic fields of different intensities. In: Bersani F, ed. Electricitry and Magnetism in Biology and Medicine. New York: Kluwer Academic/Plenum Publishers; 1999.
54. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocr Metab. 1985;60:1166-1173.
55. Aldous ME, Arendt J. Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem. 1988;25:298-303.
56. Byus CV, Pieper SE, Adey WR. The effects of low-energy 60-Hz environmental electromagnetic fields upon the growth-related enzyme ornithine decarboxylase. Carcinogenesis. 1987;8:1385-1389.
57. Kumlin T, Alhonen L, Janne J, Lang S, Kosma V-M, Juutilainen J. Epidermal ornithine decarboxylase and polyamines in mice exposed to 50 Hz magnetic fields and UV radiation. Bioelectromagnetics. 1998;19:388-391.
58. Bowman J, Methner MM. Hazard surveillance for industrial magnetic fields 11. Field characteristics from waveform capture. Ann Occup Hyg. 2000;44:615-633.
59. Valberg P. Designing EMF experiments: what is required to characterize 'exposure'? Bioelectromagnetics. 1995;16: 396-406.
60. Brain JD, Kavet R, McCormick DL, et al. Childhood leukemia: electric and magnetic fields as possible risk factors. Environ Health Perspect. 2003;111:962-970.
61. Eichwald C, Walleczek J. Activation-dependent and biphasic electromagnetic field effects: model based on cooperative enzyme kinetics and cellular signaling. Bioelectromagnetics. 1996;17:427-435.
62. Marino AA, Wolcott M, Chervenak R, Jourd'Heul F, Nilsen E, Frilot C. Nonlinear response of the immune system to power-frequency magnetic fields. Am J Physiol Regul Integr Comp Physiol. 2000;279:R761-R768.
63. Calvo JR, Rafii-Idrissi M, Pozo D, Guerrero JM. Immunomodulatory role of melatonin: binding sites in human and rodent lymphoid cells. J Pineal Res. 1995;18: 119-126.
64. Ram PT, Yuan L, Dai J, et al. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J Pineal Res. 2000;28: 210-218.
65. Di Carlo AL, Litovitz TA. Is genetics the unrecognized confounding factor in bioelectromagnetics? Flock-dependence of field-induced anoxia protection in chick embryos. Bioelectrochem. Bioenergetics. 1999;48:209-215.
66. Levallois P. Hypersensitivity of human subjects to environmental electric and magnetic field exposure: a review of the literature. Environ Health Perspect. 2002;110(Suppl 4):613-618.